Clinical Trial Update: The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of combining bortezomib with fludarabine and cytarabine in mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Tingbo Liu | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: UNKNOWN